Co-Authors
This is a "connection" page, showing publications co-authored by KUMUDHA BALAKRISHNAN and ALESSANDRA FERRAJOLI.
Connection Strength
0.066
-
A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL. Oncotarget. 2017 Mar 28; 8(13):22104-22112.
Score: 0.037
-
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2014 Jun; 14(3):231-8.
Score: 0.029